The present and future of specific prophylaxis of influenza and other acute viral respiratory diseases.
D000208:Acute Disease; D000328:Adult; D000547:Amantadine / Q000008:administration & dosage; D000818:Animals; D000956:Antigens, Viral; D000998:Antiviral Agents / Q000008:administration & dosage*; D001952:Bridged-Ring Compounds / Q000008:administration & dosage; D002642:Chick Embryo; D002648:Child; D004196:Disease Outbreaks; D006388:Hemagglutinins; D006801:Humans; D007114:Immunization; D007116:Immunization, Passive; D007252:Influenza Vaccines / Q000008:administration & dosage; D007251:Influenza, Human / Q000276:immunology / Q000517:prevention & control* / Q000628:therapy; D007369:Interferon Inducers / Q000627:therapeutic use; D009439:Neuraminidase / Q000276:immunology; D009975:Orthomyxoviridae / Q000145:classification / Q000276:immunology; D012106:Research; D012141:Respiratory Tract Infections / Q000517:prevention & control*; D014765:Viral Vaccines; D014777:Virus Diseases / Q000517:prevention & control*
D000956:Antigens, Viral; D000998:Antiviral Agents; D001952:Bridged-Ring Compounds; D006388:Hemagglutinins; D007252:Influenza Vaccines; D007369:Interferon Inducers; D014765:Viral Vaccines; D000547:Amantadine; D009439:Neuraminidase